Literature DB >> 34211593

Synthesis of Disulfide-Bridging Trehalose Polymers for Antibody and Fab Conjugation Using a Bis-Sulfone ATRP Initiator.

Neil L Forsythe1, Heather D Maynard1.   

Abstract

Antibodies and antigen binding fragments (FABs) are widely used as therapeutics and conjugated polymers can enhance the properties of these important biomolecules. However, limitations to the selectivity and stability of current conjugation methodologies can inhibit the exploration of new antibody-polymer conjugates. Herein, we describe a new strategy for the synthesis of these conjugates that forms a stable thioether bond and can be directly incorporated into an atom transfer radical polymerization (ATRP) initiator. Specifically, a bis-sulfone alkyl bromide initiator was synthesized and utilized in the activators generated by electron transfer (AGET) ATRP of ethylene glycol methacrylate and trehalose methacrylate to form the respective polymers. The trehalose polymer was then irreversibly inserted into the disulfide bonds of Herceptin and Herceptin FAB after mild reduction to form the conjugates with quantitative conversions as verified by Western Blot and mass spectrometry after cleavage of the polymer. The binding of the Herceptin and Herceptin Fab conjugates to the receptor was investigated by indirect ELISA (enzyme-linked immunosorbent assay) and the EC50's were 0.90 and 2.74 nM, respectively, compared to Herceptin (0.26 nM) and the Fab (0.56 nM). The conjugates were subjected to heating studies at a constant 75 °C, the temperature determined in a heat ramp to be the threshold of stability for the antibody and FAB; the trehalose polymer was found to considerably increase the thermal stability of both Herceptin and Herceptin Fab. This work provides a new way to prepare polymer-antibody/Fab conjugates utilizing bis-sulfone end groups installed by atom transfer radical polymerization of the functionalized initiators and a way to stabilize these important molecules by conjugation to trehalose polymers.

Entities:  

Year:  2021        PMID: 34211593      PMCID: PMC8240515          DOI: 10.1039/d0py01579b

Source DB:  PubMed          Journal:  Polym Chem        ISSN: 1759-9954            Impact factor:   5.582


  39 in total

Review 1.  Antibody structure, instability, and formulation.

Authors:  Wei Wang; Satish Singh; David L Zeng; Kevin King; Sandeep Nema
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

Review 2.  Monoclonal antibodies as innovative therapeutics.

Authors:  Janice M Reichert
Journal:  Curr Pharm Biotechnol       Date:  2008-12       Impact factor: 2.837

3.  Antibody fragments: hope and hype.

Authors:  Aaron L Nelson
Journal:  MAbs       Date:  2010-01-27       Impact factor: 5.857

4.  Aggregation stability of a monoclonal antibody during downstream processing.

Authors:  Paolo Arosio; Giuliano Barolo; Thomas Müller-Späth; Hua Wu; Massimo Morbidelli
Journal:  Pharm Res       Date:  2011-03-30       Impact factor: 4.200

5.  Site-selective in situ growth of fluorescent polymer-antibody conjugates with enhanced antigen detection by signal amplification.

Authors:  Libin Zhang; Wenguo Zhao; Xinyu Liu; Guilin Wang; Yang Wang; Dong Li; Liangzhi Xie; Yan Gao; Haiteng Deng; Weiping Gao
Journal:  Biomaterials       Date:  2015-06-17       Impact factor: 12.479

6.  Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis.

Authors:  Hongcheng Liu; Chris Chumsae; Georgeen Gaza-Bulseco; Karen Hurkmans; Czeslaw H Radziejewski
Journal:  Anal Chem       Date:  2010-06-15       Impact factor: 6.986

7.  Contribution of linker stability to the activities of anticancer immunoconjugates.

Authors:  Stephen C Alley; Dennis R Benjamin; Scott C Jeffrey; Nicole M Okeley; Damon L Meyer; Russell J Sanderson; Peter D Senter
Journal:  Bioconjug Chem       Date:  2008-03-04       Impact factor: 4.774

8.  Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates.

Authors:  Robert P Lyon; Jocelyn R Setter; Tim D Bovee; Svetlana O Doronina; Joshua H Hunter; Martha E Anderson; Cindy L Balasubramanian; Steven M Duniho; Chris I Leiske; Fu Li; Peter D Senter
Journal:  Nat Biotechnol       Date:  2014-09-07       Impact factor: 54.908

9.  Optimisation of the dibromomaleimide (DBM) platform for native antibody conjugation by accelerated post-conjugation hydrolysis.

Authors:  Maurício Morais; João P M Nunes; Kersti Karu; Nafsika Forte; Irene Benni; Mark E B Smith; Stephen Caddick; Vijay Chudasama; James R Baker
Journal:  Org Biomol Chem       Date:  2017-04-05       Impact factor: 3.876

10.  Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis.

Authors:  Chris P Ryan; Mark E B Smith; Felix F Schumacher; Dina Grohmann; Danai Papaioannou; Gabriel Waksman; Finn Werner; James R Baker; Stephen Caddick
Journal:  Chem Commun (Camb)       Date:  2011-04-05       Impact factor: 6.222

View more
  1 in total

Review 1.  Synthesis and Application of Trehalose Materials.

Authors:  Daniele Vinciguerra; Madeline B Gelb; Heather D Maynard
Journal:  JACS Au       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.